PTC Therapeutics
PTCT · NASDAQ
Bulios Fair Price
$81.27
28.1% upside
Trenutna cena
$63.46
Po podatkih Bulios Fair Price je delnica PTCT trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
PTC Therapeutics, Inc. is an American biotechnology company that specializes in the development and commercialization of drugs for genetic and rare diseases. Founded in 1998, the company focuses on molecular therapies and innovative approaches to treating conditions that lack sufficient treatment options. PTC Therapeutics is dedicated to researching and developing drugs that target the genetic mechanisms of diseases, including conditions like Duchenne muscular dystrophy and other rare genetic disorders. The company has a global reach, with its drugs distributed in various countries.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
Matthew Klein
Employees
991
Headquarters
Warren
Prihajajoči dogodki
Earnings
Upcoming earnings report